- Press Contact
- Global Marketing Manager
- Europe and Asia-Pacific
Novus Scientific (Uppsala, Sweden) is pleased to announce the start of the randomized controlled multicenter study PREVMESH. The study aims at assessing whether a long-term resorbable mesh (TIGR®Matrix) placed onlay after open abdominal surgery decreases the rate of incisional hernias and wound dehiscence.
Data presented from Swedish validated registries showing risk factors for burst abdomen and incisional hernias after open abdominal surgery. By combining such risk factors, the authors believe they will be able to define those patients at greater risk for wound complications and find out how to treat these patients.
Safety data presented at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan. TIGR Matrix was used to prevent parastomal hernia in emergency stoma formation. TIGR Matrix was safe to use despite severely contaminated field in a large group of the patients.
Dr Bruce Ramshaw presented data from the clinical quality improvement (CQI) program at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan. Several attempts at process improvement were implemented in one hernia program over a three-year period. This led to decreased costs and improved outcomes for patients who underwent abdominal wall reconstruction.
Novus Scientific, the Swedish-based creator of TIGR® Matrix Surgical Mesh, will be exhibiting at this five-day meeting, which is the first of its kind in the world.
In November more than 90 breast surgeons gathered in Birmingham to learn more about the iBRA study. The aim of the study is to prospectively collect data in implant-based reconstruction after breast cancer across the UK. The goal is to include data for more than 1000 women and in december data for more than 300 women were included. Dr Peter Schrenk presented his data for implant based reconstruction with TIGR Matrix.
The iBRA study commented in Medical plastic News.
Novus Responds to Need for Mid-Sized Matrix in Breast Reconstruction
Great interest for TIGR Matrix at the ORBS meeting
Dr. Todd Heniford talked with Novus about the newest technology in synthetic surgical mesh and (see content of story) statistical analysis of abdominal wall surgeries. Mike Smith’s interview at AWR appears in ‘Becker’s’ journal. The 25th anniversary edition of Surgical Technology International, a leading industry publication, was released today sponsored by Novus Scientific available at ASPS.
Dr. Torbjorn Mathiesen, Chief Technology Officer of Novus Scientific writes an article entitled, "Flexibility, Porosity Design Leads to Regeneration of Soft Tissue" in Medical Design Technology. The article details the thought process and steps taken by Mathiesen when creating TIGR Matrix surgical mesh.
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable inplants, that is aimed to help the body to heal it self.
Global HQ, Resaerch and manufacturing is in Uppsala, Sweden. The US Division, Novus Scientific, Inc. is headquartered in San Diego.
E-mail has been sent